-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 8, Youhe Pharmaceutical, a wholly-owned subsidiary of Biocytometer, announced on September 7 that its CD40 (YH003) China Phase I clinical study number was YH003003 and completed the first patient medication
This study is a multi-center, open-ended, phase I dose escalation study evaluating the safety, tolerability and pharmacokinetics of YH003 in patients with advanced solid tumors
Note: The original text has been deleted